XML 138 R78.htm IDEA: XBRL DOCUMENT v3.25.1
Share-based compensation - Options - Activity (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Number of Options    
Number of options, beginning of period (in shares) 462,340  
Granted (in shares) 697,629  
Forfeited (in shares) 0  
Exercised (in shares) 0  
Expired (in shares) 0  
Number of options, end of period (in shares) 1,159,969 462,340
Number of options, vested and exercisable (in shares) 373,824  
Weighted Average Exercise Price    
Weighted average exercise price, beginning of period (in dollars per share) $ 2.37  
Granted (in dollars per share) 1.46  
Weighted average exercise price, end of period (in dollars per share) 1.82 $ 2.37
Weighted Average Grant Date Fair Value    
Weighted average grant date fair value, beginning of period (in dollars per share) 1.20  
Weighted average grant date fair value, granted (in dollars per share) 0.82  
Weighted average grant date fair value, end of period (in dollars per share) $ 0.96 $ 1.20
Weighted Average Remaining Contractual Term    
Weighted average remaining contractual term, outstanding 8 years 6 months 21 days 9 years 4 months 6 days
Weighted average remaining contractual term, granted 10 years  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest [Abstract]    
Weighted average exercise price, vested and exercisable (in dollars per share) $ 2.43  
Weighted average grant date fair value - vested and exercisable (in dollars per share) $ 1.18  
Weighted average remaining contractual term, vested and exercisable 7 years 5 months 8 days  
Average Intrinsic Value    
Aggregate intrinsic value, beginning balance $ 0  
Aggregate intrinsic value, granted 0  
Aggregate intrinsic value, ending balance 0 $ 0
Aggregate intrinsic value, vested and exercisable $ 0